Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-228-5 | CAS number: 79-81-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin irritation / corrosion
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (irritating)
Eye irritation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Additional information
Skin irritation:
In the key study, semiocclusive dermal administration of the test substance (approx. 95% retinyl palmitate) to New Zealand White Rabbits for 4 hours resulted in reversible erythema and no edema was observed (DSM 221051). The mean scores for erythema was 1.7 (24, 48 and 72 hours) for each animal. Reversible scaling was observed in 1 of 3 animals. Therefore, the test substance was found to be slightly irritating.
In the supportive study, occlusive dermal administration of the test substance in arachis oil (approx. 95% retinyl palmitate) to Vienna White rabbits for 4 hours resulted mostly in reversible erythema (1/6 animals showed slight erythema at the end of the observation period) and fully reversible edema (BASF 82/202-205). The mean scores for erythema and edema was 1.9 and 0.7 (24, 48 and 72 hours, all animals). Furthermore, desquamation was found in all animals at the 8 day reading. At control sites, only very slight skin irritation was observed with arachis oil DAB 8. Therefore, the test substance was found to be irritating on the basis of the scaling observed in all animals and the lack of reversibility for erythema in 1 of 6 animals. However, testing has not been performed according to current standart protocols (occlusive application, observation period 8 days).
Further evidences for dermal irritation is provided by structurally similar retinyl ester, i.e retinyl propionate and retinyl acetate:
In the key study for skin irritation performed according to GLP and OECD guideline 404, using New Zealand White Rabbits and retinyl propionate (purity approx. 90%), reversible erythema and edema was observed (DSM B-154`448). Individual erythema mean scores (24 -72 hrs) were >=2 (but <2.3 in 2/3 animals) and reversible desquamation or scabbing, epidermal lesions and scaling was observed in 3/3 animals. Therefore retinyl propionate was identified to be irritating to the skin.
In the key study for skin irritation according to GLP and OECD guideline 404, New Zealand White Rabbits were treated with retinyl acetate (1.5 mlU/g) (DSM 221040). The mean scores for erythema was 1.4 (24, 48 and 72 hours, 3 animals), and none of the animals showed a mean erythema score >=2. The erythema observed was fully reversible within 14 days and scaling was observed in 1/3 animals. None of the animals showed edema. Considering the given information on test substance concentration, i.e. 1.5 mlU/g, as 1500000 IU/g, a concentration of retinyl acetate in the tested substance is assumed to be 516 mg/g or approx 52%.
In the key study for skin irritation according to the OECD guideline 404 (deviation from current guideline: occlusive application, observation period), retinyl acetate (860 mg/g test substance or 86% in the test substance) induced mean scores for erythema of 2.3 and edema of 1.0 (24, 48 and 72 hours, 6 animals) in Vienna White rabbits (BASF 82/202-205). Erythema were found to be not fully reversible in 5/6 animals until the end of the observation period (8 days), whereas edema fully reversed within 8 days. Scaling was observed in 6/6 animals at the end of the study.
Althought the present key study on retinyl palmitate does not meet the criteria for classification as a skin irritant according to directive 67/548/EEC, the supportive study and the findings from structurally similar substances, i.e retinyl acetate and retinyl propionate, provide evidence for dermal irritative potential of this substance group, warranting a respective classification. However, the dermal irritative potential of retinyl palmitate appears to be lower than for retinyl acetate and retinyl propionate on the basis of the present data.
Eye irritation:
The key study for eye irritation was performed according to GLP and OECD guideline 405, using New Zealand White Rabbits and undiluted test substance (approx. 95% retinyl palmitate; DSM 221016). For eye irritation the mean irritation score (24 and 48 and 72 hrs) for conjuctival redness was 0.3, in 1/3 animals. No effects on corneal opacity, iris lesion or chemosis of the conjuctivae were noted. No adverse effects on the eye was noted after administration of the test substance when diluted (30%). The test substance was not an eye irritant under the conditions of the study.
Effects on skin irritation/corrosion: irritating
Justification for classification or non-classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.